Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Arrowhead Research Corporation (ARWR)

Pharmaceutical Preparations

https://www.arrowheadpharma.com

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

177 E COLORADO BLVD, SUITE 700
PASADENA, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/06/1997

Market Cap

2,798,330,650

Shares Outstanding

107,430,000

Weighted SO

123,222,210

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

WVE --.--%

CTMX --.--%

ASMB --.--%

NLTX --.--%

BMRN --.--%

INCY --.--%

IONS --.--%

APLS --.--%

PRQR --.--%

Beta

0.9370

Last Div

0.0000

Range

20.67-39.83

Chg

-0.1500

Avg Vol

1046914

Mkt Cap

2798330650

Exch

NASDAQ

Country

US

Phone

626 304 3400

DCF Diff

46.9045

DCF

-23.3330

Div Yield

0.0000

P/S

142.4232

EV Multiple

-6.0984

P/FV

8.4579

Div Yield %

0.0000

P/E

-5.1904

PEG

-0.2467

Payout

0.0000

Current Ratio

4.6535

Quick Ratio

4.6535

Cash Ratio

0.7176

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

556.0130

CCC

-556.0130

Gross Margin

0.1129

Op Margin

-27.8505

Pretax Margin

-27.9241

Net Margin

-27.4143

Eff Tax Rate

0.0112

ROA

-0.6095

ROE

-1.7290

ROCE

-0.6953

NI/EBT

0.9817

EBT/EBIT

1.0026

EBIT/Rev

-27.8505

Debt Ratio

0.3871

D/E

1.0349

LT Debt/Cap

0.5041

Total Debt/Cap

0.5086

Int Coverage

-42.8208

CF/Debt

-1.0257

Equity Multi

2.6736

Rec Turnover

0.0000

Pay Turnover

0.6565

Inv Turnover

0.0000

FA Turnover

0.0468

Asset Turnover

0.0222

OCF/Share

-2.8252

FCF/Share

-4.2833

Cash/Share

3.5159

OCF/Sales

-17.8589

FCF/OCF

1.5161

CF Coverage

-1.0257

ST Coverage

-57.9699

CapEx Coverage

-1.9377

Div&CapEx Cov

-1.9377

P/BV

8.4579

P/B

8.4579

P/S

142.4232

P/E

-5.1904

P/FCF

-5.2602

P/OCF

-7.9675

P/CF

-7.9675

PEG

-0.2467

P/S

142.4232

EV Multiple

-6.0984

P/FV

8.4579

DPS

0.0000

Latest Headlines (EST)

Benzinga Jan 02, 15:00 4 Analysts Assess Arrowhead Pharma: What You Need To Know Benzinga Dec 29, 08:34 Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback

Revenue Product Segmentation